Voquezna Triple Pak Kit
Product Images NDC 81520-255

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Voquezna Triple Pak (NDC 81520-255). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phathom Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Voquezna 01)

FDA Label Image

Chemical Structure (Voquezna 02)

FDA Label Image

Chemical Structure (Voquezna 03)

FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
This is a description of a medication called VOQUEZNA DualPak sold by Phathom Pharmaceuticals. It contains two types of tablets/capsules, vonoprazan tablets with a dose of 20mg and amoxicillin capsules with a dose of 500mg. The package comes with 28 tablets and 84 capsules inside a carton. The medication is co-packaged for oral use and should be kept out of reach of children. The NDC numbers for the medication are 81520-250-14 and it is available only by prescription.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
The given text is a description of VOQUEZNA TriplePak, a medicine for oral use, containing vonoprazan tablets (20 mg), amoxicillin capsules (500 mg), and clarithromycin tablets (500 mg). It is a triple therapy designed to treat certain bacterial infections. Each carton contains 56 tablets and 56 capsules for 14 days of treatment. The pack is marked as Rx only and must be kept away from the reach of children. The remaining text contains illegible characters and errors.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.